Company Filing History:
3 out of 135 
1 out of 4,316 
Years Active: 2014-2019
Title: Innovations by Richard Li-Chern Pan
Introduction
Richard Li-Chern Pan is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the fields of microfluidics and cancer research. With a total of three patents to his name, his work focuses on innovative solutions for sperm acquisition and tumor cell capture.
Latest Patents
One of his latest patents is titled "Microfluidic chips for acquiring sperms with high motility, productions and applications thereof." This invention relates to microfluidic chips designed to acquire sperms with high velocity and motility. The microfluidic chip comprises an inlet region, a first flow channel, a divergent channel, an optional block structure with rounded corners, and one or more outlet regions. The invention mimics the sperm activation process in the body, allowing for the acquisition of a higher population of sperms with high motility.
Another significant patent is the "Kit and method for the capture of tumor cells." This invention provides a kit and method for capturing living tumor cells from a body fluid sample. The kit can distinguish between living tumor cells and non-living tumor cells or cell fragments. This capability allows for further identification of tumor species through the culture of captured tumor cells. The method can readily identify whether a sample contains tumor cells, aiding in the detection of cancer and the monitoring of metastasis and early relapse.
Career Highlights
Richard has worked with prestigious institutions such as Taipei Medical University and Tsinghua University. His work in these institutions has contributed to advancements in medical technology and research.
Collaborations
He has collaborated with notable colleagues, including Fang-Chi Hsu and Fan-Gang Tseng, further enhancing the impact of his research and innovations.
Conclusion
Richard Li-Chern Pan's contributions to microfluidics and cancer research through his innovative patents demonstrate his commitment to advancing medical technology. His work continues to influence the fields of reproductive health and oncology.